![Zachary Roberts](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 418 923 $ am 31.05.2026
Zachary Roberts currently works at Allogene Therapeutics, Inc., as Chief Medical Officer & Executive Vice President from 2023.
Dr. Roberts also formerly worked at Amgen, Inc., as Director-Clinical Medical Research in 2015, Instil Bio, Inc., as Chief Medical Officer from 2020 to 2022, and Kite Pharma, Inc., as Vice President-Clinical Development from 2018 to 2019.
Dr. Roberts received his undergraduate degree from the University of Maryland and doctorate degree from the University of Maryland School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 193’052 ( 0.06% ) | 418 923 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 03.01.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| INSTIL BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 11.11.2022 |
| KITE PHARMA INC | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2019 |
| AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2015 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland School of Medicine
 University of Maryland School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Instil Bio, Inc.
 Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
